Targeting inflammatory pathways for the treatment of cardiovascular disease. - Wikidata - wikimedia - TriplyDB

Targeting inflammatory pathways for the treatment of cardiovascular disease.

Targeting inflammatory pathways for the treatment of cardiovascular disease.

http://www.wikidata.org/entity/Q42410556

about

Addressing the Global Burden of Trauma in Major Surgery Inflammation and C-reactive protein in atrial fibrillation: cause or effect?The Role of Emerging Risk Factors in Cardiovascular Outcomes Protective effects of methotrexate against ischemic cardiovascular disorders in patients treated for rheumatoid arthritis or psoriasis: novel therapeutic insights coming from a meta-analysis of the literature data.Anti-inflammatory therapies for cardiovascular disease Effects of an antisense oligonucleotide inhibitor of C-reactive protein synthesis on the endotoxin challenge response in healthy human male volunteers Inflammation and cardiovascular disease: from pathogenesis to therapeutic target.Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.Natural Biflavonoids Modulate Macrophage-Oxidized LDL Interaction In Vitro and Promote Atheroprotection In Vivo.Inflammation, venous thromboembolism, and what we can do about it.Losmapimod does not reduce cardiovascular events in patients with acute myocardial infarction.Suberanilohydroxamic Acid as a Pharmacological Kruppel-Like Factor 2 Activator That Represses Vascular Inflammation and Atherosclerosis.

P2860

Q26782817-1BD71112-52D9-4219-A8CC-722A4CAA713F Q26865381-B0826494-6BAA-42EE-851E-1D094DBDAA5F Q30234550-F536D656-4CDD-4DA6-BF98-F914C1C73CEE Q31005025-FC67667A-45BD-4FE2-B5A0-387555AFF2D4 Q34137872-BAE1FF23-FDF4-443C-9F13-051FB2FF29AF Q35026389-7DCB0283-6AF1-4B5E-A137-60198D2A0090 Q38231099-D2AE903C-AD2B-496D-8D2F-C393EA6156C5 Q38546242-4C07CCCD-22AC-4D3E-91DC-97EA5BD51D6C Q39504039-B4AC18C3-A35C-46D6-A1CA-822CBE7A8636 Q40194229-33F4FAC1-8305-4ACD-8261-CA189D8A91C8 Q42384664-723B6AAC-FEFA-4BD3-8DA5-4FC8E017B526 Q47345095-2C7C836F-F58D-47F3-93F0-D23A60169F0B

P2860

Targeting inflammatory pathways for the treatment of cardiovascular disease.

http://www.wikidata.org/entity/Q42410556

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Targeting inflammatory pathways for the treatment of cardiovascular disease.

@en

Targeting inflammatory pathways for the treatment of cardiovascular disease.

@nl

type

label

Targeting inflammatory pathways for the treatment of cardiovascular disease.

@en

Targeting inflammatory pathways for the treatment of cardiovascular disease.

@nl

prefLabel

Targeting inflammatory pathways for the treatment of cardiovascular disease.

@en

Targeting inflammatory pathways for the treatment of cardiovascular disease.

@nl

P1433

Q42410556-6B84A390-54E0-4A86-8ED0-0F8F3C39CE75

P1476

Q42410556-A23EDF97-A8EB-4C7C-8926-503BB16ECBDD

P2093

Q42410556-CB9A963A-ED8A-41C9-8BBC-4BC04D682F0F

P2860

Q42410556-230CCC76-CCEB-4A8A-8C89-7D108C47D1D8

Q42410556-35961BFC-4F17-4BEF-AE81-E7132F83CFD4

Q42410556-39142005-F341-463F-B40A-21152F32EC47

Q42410556-405D50BD-6E46-4E8E-9598-F269C200D7B1

Q42410556-5B23136F-EBF9-4CC2-A84D-B45D64412CD8

Q42410556-74E80A69-1232-4386-8BF9-2FC61971B90A

Q42410556-8107A86E-4C0F-4D84-8A02-3CB77731018B

Q42410556-830F47D8-8549-43C2-A737-C1210AEA46AB

Q42410556-9FA8F2BE-A1D7-442C-816F-46B9F59F09C4

Q42410556-A3AC056A-B7E8-4855-B5E0-68866E0B0418

P304

Q42410556-3CC240A6-005F-4F19-801C-E4DA1E9B0F12

P31

Q42410556-658fa029-9c4f-417b-95f7-1754fd4ec62a

Q42410556-CB5E667F-6079-46F2-9B00-2C8D67F82AE5

P356

Q42410556-EC0C0A06-F221-4CF8-A5B7-8EA9B9DF1BFF

P433

Q42410556-74C5A975-5249-45C2-A631-99D5FC2ADDD6

P478

Q42410556-F5BCC74E-B321-4FE4-B9BD-EE93A1579FB9

P577

Q42410556-7C329A57-4572-4B5D-85AD-6AA2AA5703F1

P5875

Q42410556-FA09D283-7450-4030-8A1D-1B59F70D8F21

P698

Q42410556-CAF19562-5D59-494E-B9A3-DBC3F6AD1F37

P921

Q42410556-5C442FBE-6B27-4200-909C-7C8AD9D6665C

Q42410556-F7D78E7D-8497-4C29-B394-990EBE78BA87

P932

Q42410556-34B78D80-6410-4FC6-A254-AA88EE842B47

P356

P1433

European Heart Journal

P1476

Targeting inflammatory pathways for the treatment of cardiovascular disease.

@en

P2093

Paul M Ridker

http://www.w3.org/2001/XMLSchema#string

P2860

Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque

Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Progress and challenges in translating the biology of atherosclerosis

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.

Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial.

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

P304

540-543

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHT398

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258350415

http://www.w3.org/2001/XMLSchema#string

P698

24204011

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

3954097

http://www.w3.org/2001/XMLSchema#string